AAAAAA

   
Results: 1-8 |
Results: 8
PROGNOSTIC MARKERS OF DISEASE-ACTIVITY IN HODGKINS-DISEASE
Authors: MARTINOW AJ YUEN K COOPER IA MATTHEWS JP JUNEJA S WOLF M JANUSZEWICZ H PRINCE HM
Citation: Aj. Martinow et al., PROGNOSTIC MARKERS OF DISEASE-ACTIVITY IN HODGKINS-DISEASE, Leukemia & lymphoma, 29(3-4), 1998, pp. 383-389
ISOLEX 300I CD34-SELECTED BLOOD-CELLS (BC) ARE CAPABLE OF SUPPORTING MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY
Authors: PRINCE HM BERTONCELLO I MILLWARD MJ CHAPPLE P RISCHIN D QUINN M BRETTELL M BARBER L WOLF M JANUSZEWICZ H JUNEJA S GATES P VANKERKHOVEN M MAISANO R TONER GC
Citation: Hm. Prince et al., ISOLEX 300I CD34-SELECTED BLOOD-CELLS (BC) ARE CAPABLE OF SUPPORTING MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY, Experimental hematology, 26(8), 1998, pp. 68-68
PERIPHERAL-BLOOD CD34(+) CELL COUNT RELIABLY PREDICTS AUTOGRAFT YIELD
Authors: CHAPPLE P PRINCE HM QUINN M BERTONCELLO I JUNEJA S WOLF M JANUSZEWICZ H BRETTELL M GARDYN J SEYMOUR C VENTER D
Citation: P. Chapple et al., PERIPHERAL-BLOOD CD34(+) CELL COUNT RELIABLY PREDICTS AUTOGRAFT YIELD, Bone marrow transplantation, 22(2), 1998, pp. 125-130
PROGNOSTIC FACTORS IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML) ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC)
Authors: GILES FJ KUSUANCO D LYNOTT A SHAH PM WANG LX SUPANDIMAN I POOVALINGAM V RANA F AZIZ F CHEN YC DUTOIT PJ JANUSZEWICZ H TEE GY WOLF M SUMANTRI R ALOMARI K TIAN D BEZWODA WR ABDI E GONZAGA M FAHED F FOURIE LS RUFF P POOL R KIM HC PARIKH PM KIM KY HO BS TAN P LEE SN TIEN SL WIJONO A LOBERIZA S LEE GH KIM SY HO CH BAYLON H AHN MJ THOMAS M WOLF M TIEN HF AYDOGDU I TAM J LIM SW CAVILEZ A
Citation: Fj. Giles et al., PROGNOSTIC FACTORS IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML) ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC), British Journal of Haematology, 102(1), 1998, pp. 187-187
HYPEREOSINOPHILIC SYNDROME OR CHRONIC EOSINOPHILIC LEUKEMIA - REPORT OF A CASE WITH A LYTIC BONE LESION
Authors: JUNEJA S STEWART J MCKENZIE A VENTER D JANUSZEWICZ H
Citation: S. Juneja et al., HYPEREOSINOPHILIC SYNDROME OR CHRONIC EOSINOPHILIC LEUKEMIA - REPORT OF A CASE WITH A LYTIC BONE LESION, Leukemia, 11(5), 1997, pp. 765-766
PERIPHERAL-BLOOD CD34 COUNT IS PREDICTIVE OF APHERESIS PRODUCT CD34 CONTENT
Authors: WOLF M CHAPPLE P PRINCE HM JUNEJA S JANUSZEWICZ H QUINN M VENTER D
Citation: M. Wolf et al., PERIPHERAL-BLOOD CD34 COUNT IS PREDICTIVE OF APHERESIS PRODUCT CD34 CONTENT, Experimental hematology, 25(8), 1997, pp. 313-313
PERIPHERAL-BLOOD CD34 COUNT IS A RELIABLE PREDICTOR OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFT YIELD
Authors: PRINCE HM CHAPPLE P QUINN M JUNEJA S WOLF M JANUSZEWICZ H BRETELL M VENTER D
Citation: Hm. Prince et al., PERIPHERAL-BLOOD CD34 COUNT IS A RELIABLE PREDICTOR OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFT YIELD, Blood, 90(10), 1997, pp. 927-927
REDUCTION OF PULMONARY TOXICITY BY PREDNISOLONE PROPHYLAXIS DURING ALL-TRANS-RETINOIC ACID TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors: WILEY JS FIRKIN FC BRADSTOCK K WILEY J WOLF M ATKINSON K CHONG B CATALANO J DALE B DAVIES J DODDS A ENNO A FIRKIN F FROST T GRIGG A JANUSZEWICZ H KOUTTS J LIND D LEE N LOWENTHAL R MA D MILLIKAN S PHADKE K ROZENBERG M SAGE E SCHWARER A SZER J VANDERWEYDEN M WOODRUFF R
Citation: Js. Wiley et al., REDUCTION OF PULMONARY TOXICITY BY PREDNISOLONE PROPHYLAXIS DURING ALL-TRANS-RETINOIC ACID TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia, 9(5), 1995, pp. 774-778
Risultati: 1-8 |